comparemela.com

Page 3 - Aslan Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ADRs Close Lower; Ambow Education Holding Ltd Declines 23 3%

Isocitrate Dehydrogenase (IDH) Inhibitors Market Secures Remarkable Valuation of US$39 16 Billion in

Isocitrate Dehydrogenase (IDH) Inhibitors MarketThe isotrate dehydrogenase (IDH) inhibitors market sales is predicted to expand from US$ 1.7 billion in 2022 to US$ 39.16 billion in 2033, with a compound annual growth rate (CAGR) of 33% from 2023 to 2033.Additionally, the development of more potent and selective IDH.

Short Interest in ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Decreases By 24 4%

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN – Get Free Report) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 53,700 shares, a decline of 24.4% from the December 31st total of 71,000 shares. Currently, 0.3% of the shares of the company are sold short. Based […]

ADRs End Lower; Aslan Pharmaceuticals Declines 38%

This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed lower on Tuesday, as the S&P/BNY Mellon index. -January 16, 2024 at 04:55 pm EST - MarketScreener

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.